Last reviewed · How we verify
co.don AG — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| co.don chondrosphere® | co.don chondrosphere® | phase 3 | Cell-based therapy | Orthopedics |
Therapeutic area mix
- Orthopedics · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- State-Financed Health Facility "Samara Regional Medical Center Dinasty" · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for co.don AG:
- co.don AG pipeline updates — RSS
- co.don AG pipeline updates — Atom
- co.don AG pipeline updates — JSON
Cite this brief
Drug Landscape (2026). co.don AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/co-don-ag. Accessed 2026-06-10.